Risk profile of subcutaneous port placement in small children

Richard E Overman1, Alejandra M Casar Berazaluce2, Kyle Van Arendonk3

  • 1Division of Pediatric Surgery, Department of Surgery, CS Mott Children's Hospital, University of Michigan, Ann Arbor, MI.

Insights

Children weighing less than 10 kg can safely undergo port placement. This study found no significant difference in port complications for pediatric patients under 10 kg compared to those over 10 kg.

Area of Science:

  • Pediatric Surgery
  • Vascular Access Devices

Background:

  • Long-term central venous access is crucial for pediatric patients.
  • Complications associated with port placement are a concern, particularly in smaller children.
  • Some surgeons avoid port placement in children under 10 kg due to perceived higher morbidity.

Purpose of the Study:

  • To evaluate the association between patient weight (= 10 kg) and port complications in children.
  • To determine if a weight cutoff should be used for port placement in pediatric patients.

Main Methods:

  • Multi-institutional retrospective review of 500 pediatric patients (<5 years) undergoing port placement.
  • Patients were stratified into two groups: weight <10 kg and weight >10 kg at the time of insertion.
  • Statistical analysis was performed to compare complication rates and outcomes between the groups.

Main Results:

  • The overall complication rate was 22% (28.9% in <10 kg group vs. 20.6% in >10 kg group; p=0.096).
  • No significant differences were observed in complication type, timing, or port removal rates between the weight groups.
  • Complication rates per port-day were similar, with no statistically significant difference between groups (<10 kg: 0.68/1000 port-days vs. >10 kg: 0.44/1000 port-days; p=0.068).

Conclusions:

  • Patient weight less than 10 kg was not associated with a significantly higher incidence of port complications.
  • The findings suggest that weight alone should not be a contraindication for port placement in pediatric patients.
  • This study supports the consideration of port placement in younger and smaller children based on clinical need.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
150
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
131
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
125
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
100
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K